NuGen Medical Devices Inc. (TSXV:NGMD)
0.0200
0.00 (0.00%)
Jun 11, 2026, 4:00 PM EST
NuGen Medical Devices Revenue
NuGen Medical Devices had revenue of 24.67K CAD in the quarter ending March 31, 2026, a decrease of -78.89%. This brings the company's revenue in the last twelve months to 165.74K, down -84.65% year-over-year. In the year 2025, NuGen Medical Devices had annual revenue of 257.95K, down -74.46%.
Revenue (ttm)
165.74K
Revenue Growth
-84.65%
P/S Ratio
27.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 257.95K | -751.93K | -74.46% |
| Dec 31, 2024 | 1.01M | 678.48K | 204.73% |
| Dec 31, 2023 | 331.40K | 179.05K | 117.52% |
| Dec 31, 2022 | 152.36K | 14.71K | 10.69% |
| Dec 31, 2021 | 137.65K | 90.35K | 191.04% |
| Dec 31, 2020 | 47.30K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurora Spine | 25.67M |
| Perimeter Medical Imaging AI | 2.98M |
| Cheelcare | 1.63M |
| Conavi Medical | 778.00K |
| Frequency Exchange | 745.08K |
| MedX Health | 539.93K |
| Ventripoint Diagnostics | 179.93K |
| VVT Med | 156.00K |
NuGen Medical Devices News
- 16 days ago - NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance - Newsfile Corp
- 2 months ago - NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology - Newsfile Corp
- 4 months ago - NuGen Medical Devices Inc. Provides Update on Health Canada License - Newsfile Corp
- 4 months ago - NuGen Medical Devices Inc. Announces CFO Transition - Newsfile Corp
- 5 months ago - NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress - Newsfile Corp
- 9 months ago - NuGen Medical Devices Announces NHS Drug Tariff Approval for EziAutoJector(R) Product Line in the UK - Newsfile Corp
- 9 months ago - NuGen Capital Management to Invest $100MM in Solar Energy Projects - Business Wire
- 10 months ago - Nugen Raises Pre-Seed to Pioneer Reliable AI for Businesses - Business Wire